Factors influencing cytomegalovirus seropositivity in stem cell transplant patients and donors

Haematologica

Volumn 92, Issue 8, 2007, Pages 1139-1142

  Ljungman, Per ^a   Brand, Ronald ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

CMV; Serology; Stem cell transplantation

Indexed keywords

ADULT; AGE; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOMEGALOVIRUS; FEMALE; GENDER; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PROBABILITY; RISK ASSESSMENT; SEROLOGY; SEX RATIO; STEM CELL TRANSPLANTATION; ADOLESCENT; ALLOTRANSPLANTATION; BLOOD; CHILD; CYTOMEGALIC INCLUSION BODY DISEASE; DONOR; EPIDEMIOLOGY; EUROPE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOLOGY; INFANT; MIDDLE AGED; PRESCHOOL CHILD; REGISTER; RISK FACTOR; SEX DIFFERENCE; STATISTICS;

VIRUS ANTIBODY;

ADOLESCENT; ADULT; AGE FACTORS; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; EUROPE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; MALE; MIDDLE AGED; REGISTRIES; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; SEX FACTORS; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 35748972682     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.11061     Document Type: Article

References (18)

1. Boeckh M, Nichols WG. The impact of cytomegalovirus serostatus of donor and recipient before hematopoietic stem cell transplantation in the era of antiviral prophylaxis and preemptive therapy. Blood 2004;103:2003-8.
2. Craddock C, Szydlo RM, Dazzi F, Olavarria E, Cwynarski K, Yong A, et al. Cytomegalovirus seropositivity adversely influences outcome after T-depleted unrelated donor transplant in patients with chronic myeloid leukaemia: the case for tailored graft-versus-host disease prophylaxis. Br J Haematol 2001; 112:228-36.
3. Broers AE, van Der Holt R, van Esser JW, Gratama JW, Henzen-Logmans S, Kuenen-Boumeester V, et al. Increased transplant-related morbidity and mortality in CMV- seropositive patients despite highly effective prevention of CMV disease after allogeneic T-cell-depleted stem cell transplantation. Blood 2000; 95:2240-5.
4. Bowden RA, Sayers M, Flournoy N, Newton B, Banaji M, Thomas ED, et al. Cytomegalovirus immune globulin and seronegative blood products to prevent primary cytomegalovirus infection after marrow transplantation. N Engl J Med 1986;314:1006-10.
5. Ljungman P, Larsson K, Kumlien G, Aschan J, Barkholt L, Gustafsson-Jernberg A, et al. Leukocyte depleted, unscreened blood products give a low risk for CMV infection and disease in CMV seronegative allogeneic stem cell transplant recipients with seronegative stem cell donors. Scand J Infect Dis 2002;34:347-50.
6. Ljungman P, Einsele H, Frassoni F, Niederwieser D, Cordonnier C. Donor CMV serological status influences the outcome of CMV-seropositive recipients after unrelated donor stem cell transplantation; An EBMT Megafile analysis. Blood 2003;102:4255-60.
7. Ringden O, Schaffer M, Le Blanc K, Persson U, Hauzenberger D, Abedi MR, et al. Which donor should be chosen for hematopoietic stem cell transplantation among unrelated HLA-A, -B, and -DRB1 genomically identical volunteers? Biol Blood Marrow Transplant 2004;10:128-34.
8. Kollman C, Howe CW, Anasetti C, Antin JH, Davies SM, Filipovich AH, et al. Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age. Blood 2001;98:2043-51.
9. de Ory F, Ramirez R, Garcia Comas L, Leon P, Sagues MJ, Sanz JC. Is there a change in cytomegalovirus seroepidemiology in Spain? Eur J Epidemiol 2004;19:85-9.
10. Pass RF, Hutto C, Ricks R, Cloud GA. Increased rate of cytomegalovirus infection among parents of children attending day-care centers. N Engl J Med 1986;314:1414-8.
11. Adler SP. Molecular epidemiology of cytomegalovirus: viral transmission among children attending a day care center, their parents, and caretakers. J Pediatr 1988;112:366-72.
12. Adler SP. Molecular epidemiology of cytomegalovirus: evidence for viral transmission to parents from children infected at a day care center. Pediatr Infect Dis 1986;5:315-8.
13. Pass RF, Hutto SC, Reynolds DW, Polhill RB. Increased frequency of cytomegalovirus infection in children in group day care. Pediatrics 1984;74:121-6.
14. Marshall GS, Rabalais GP, Stewart JA, Dobbins JG. Cytomegalovirus seroprevalence in women bearing children in Jefferson County, Kentucky. Am J Med Sci 1993; 305:292-6.
15. Ahlfors K. IgG antibodies to cytomegalovirus in a normal urban Swedish population. Scand J Infect Dis 1984;16:335-7.
16. Hizel S, Parker S, Onde U. Seroprevalence of cytomegalovirus infection among children and females in Ankara, Turkey, 1995. Pediatr Int 1999;41:506-9.
17. Gratacap-Cavallier B, Bosson JL, Morand P, Dutertre N, Chanzy B, Jouk PS, et al. Cytomegalovirus seroprevalence in French pregnant women: parity and place of birth as major predictive factors. Eur J Epidemiol 1998;14:147-52.
18. Staras SA, Dollard SC, Radford KW, Flanders WD, Pass RF, Cannon MJ. Seroprevalence of cytomegalovirus infection in the United States, 1988-1994. Clin Infect Dis 2006;43:1143-51.